世界のファーマコビジランス市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Pharmacovigilance Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4577 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、ファーマコビジランスのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、契約アウトソーシング）、用途別市場規模（製薬＆バイオテクノロジー企業、委託研究機関（CRO）、ビジネスプロセスアウトソーシング（BPO）企業、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ファーマコビジランスの市場動向 ・企業の競争状況、市場シェア ・ファーマコビジランスの種類別市場規模（化学療法、契約アウトソーシング） ・ファーマコビジランスの用途別市場規模（製薬＆バイオテクノロジー企業、委託研究機関（CRO）、ビジネスプロセスアウトソーシング（BPO）企業、その他） ・ファーマコビジランスの北米市場規模2016-2027（アメリカ、カナダ） ・ファーマコビジランスのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ファーマコビジランスのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ファーマコビジランスの中南米市場規模2016-2027（メキシコ、ブラジル） ・ファーマコビジランスの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Eli Lilly and Company、ICON plc、Elsevier、Chiltern、Atlantic Research Group、Mapi Group、Accenture Plc.、Clinquest Group B.V.、GSK、PRA Health Sciences, Inc.） ・結論

Market Analysis and Insights: Global Pharmacovigilance Market
The global Pharmacovigilance market size is projected to reach US$ 7195.2 million by 2026, from US$ 4159.2 million in 2019, at a CAGR of 8.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmacovigilance market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmacovigilance market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmacovigilance market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmacovigilance market.

Global Pharmacovigilance Scope and Market Size
Pharmacovigilance market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pharmacovigilance market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy
Contract Outsourcing

Segment by Application
Pharma and Biotech Companies
Contract Research Organizations (CROs)
Business Process Outsourcing (BPO) Firms
Other Pharmacovigilance Service Providers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Eli Lilly and Company
ICON plc
Elsevier
Chiltern
Atlantic Research Group
Mapi Group
Accenture Plc.
Clinquest Group B.V.
GSK

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacovigilance Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Contract Outsourcing
1.3 Market by Application
1.3.1 Global Pharmacovigilance Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharma and Biotech Companies
1.3.3 Contract Research Organizations (CROs)
1.3.4 Business Process Outsourcing (BPO) Firms
1.3.5 Other Pharmacovigilance Service Providers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pharmacovigilance Market Perspective (2016-2027)
2.2 Pharmacovigilance Growth Trends by Regions
2.2.1 Pharmacovigilance Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pharmacovigilance Historic Market Share by Regions (2016-2021)
2.2.3 Pharmacovigilance Forecasted Market Size by Regions (2022-2027)
2.3 Pharmacovigilance Industry Dynamic
2.3.1 Pharmacovigilance Market Trends
2.3.2 Pharmacovigilance Market Drivers
2.3.3 Pharmacovigilance Market Challenges
2.3.4 Pharmacovigilance Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pharmacovigilance Players by Revenue
3.1.1 Global Top Pharmacovigilance Players by Revenue (2016-2021)
3.1.2 Global Pharmacovigilance Revenue Market Share by Players (2016-2021)
3.2 Global Pharmacovigilance Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pharmacovigilance Revenue
3.4 Global Pharmacovigilance Market Concentration Ratio
3.4.1 Global Pharmacovigilance Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacovigilance Revenue in 2020
3.5 Pharmacovigilance Key Players Head office and Area Served
3.6 Key Players Pharmacovigilance Product Solution and Service
3.7 Date of Enter into Pharmacovigilance Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmacovigilance Breakdown Data by Type
4.1 Global Pharmacovigilance Historic Market Size by Type (2016-2021)
4.2 Global Pharmacovigilance Forecasted Market Size by Type (2022-2027)

5 Pharmacovigilance Breakdown Data by Application
5.1 Global Pharmacovigilance Historic Market Size by Application (2016-2021)
5.2 Global Pharmacovigilance Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pharmacovigilance Market Size (2016-2027)
6.2 North America Pharmacovigilance Market Size by Type
6.2.1 North America Pharmacovigilance Market Size by Type (2016-2021)
6.2.2 North America Pharmacovigilance Market Size by Type (2022-2027)
6.2.3 North America Pharmacovigilance Market Size by Type (2016-2027)
6.3 North America Pharmacovigilance Market Size by Application
6.3.1 North America Pharmacovigilance Market Size by Application (2016-2021)
6.3.2 North America Pharmacovigilance Market Size by Application (2022-2027)
6.3.3 North America Pharmacovigilance Market Size by Application (2016-2027)
6.4 North America Pharmacovigilance Market Size by Country
6.4.1 North America Pharmacovigilance Market Size by Country (2016-2021)
6.4.2 North America Pharmacovigilance Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Pharmacovigilance Market Size (2016-2027)
7.2 Europe Pharmacovigilance Market Size by Type
7.2.1 Europe Pharmacovigilance Market Size by Type (2016-2021)
7.2.2 Europe Pharmacovigilance Market Size by Type (2022-2027)
7.2.3 Europe Pharmacovigilance Market Size by Type (2016-2027)
7.3 Europe Pharmacovigilance Market Size by Application
7.3.1 Europe Pharmacovigilance Market Size by Application (2016-2021)
7.3.2 Europe Pharmacovigilance Market Size by Application (2022-2027)
7.3.3 Europe Pharmacovigilance Market Size by Application (2016-2027)
7.4 Europe Pharmacovigilance Market Size by Country
7.4.1 Europe Pharmacovigilance Market Size by Country (2016-2021)
7.4.2 Europe Pharmacovigilance Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pharmacovigilance Market Size (2016-2027)
8.2 Asia-Pacific Pharmacovigilance Market Size by Type
8.2.1 Asia-Pacific Pharmacovigilance Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pharmacovigilance Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pharmacovigilance Market Size by Type (2016-2027)
8.3 Asia-Pacific Pharmacovigilance Market Size by Application
8.3.1 Asia-Pacific Pharmacovigilance Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pharmacovigilance Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pharmacovigilance Market Size by Application (2016-2027)
8.4 Asia-Pacific Pharmacovigilance Market Size by Region
8.4.1 Asia-Pacific Pharmacovigilance Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pharmacovigilance Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pharmacovigilance Market Size (2016-2027)
9.2 Latin America Pharmacovigilance Market Size by Type
9.2.1 Latin America Pharmacovigilance Market Size by Type (2016-2021)
9.2.2 Latin America Pharmacovigilance Market Size by Type (2022-2027)
9.2.3 Latin America Pharmacovigilance Market Size by Type (2016-2027)
9.3 Latin America Pharmacovigilance Market Size by Application
9.3.1 Latin America Pharmacovigilance Market Size by Application (2016-2021)
9.3.2 Latin America Pharmacovigilance Market Size by Application (2022-2027)
9.3.3 Latin America Pharmacovigilance Market Size by Application (2016-2027)
9.4 Latin America Pharmacovigilance Market Size by Country
9.4.1 Latin America Pharmacovigilance Market Size by Country (2016-2021)
9.4.2 Latin America Pharmacovigilance Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pharmacovigilance Market Size (2016-2027)
10.2 Middle East & Africa Pharmacovigilance Market Size by Type
10.2.1 Middle East & Africa Pharmacovigilance Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pharmacovigilance Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pharmacovigilance Market Size by Type (2016-2027)
10.3 Middle East & Africa Pharmacovigilance Market Size by Application
10.3.1 Middle East & Africa Pharmacovigilance Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pharmacovigilance Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pharmacovigilance Market Size by Application (2016-2027)
10.4 Middle East & Africa Pharmacovigilance Market Size by Country
10.4.1 Middle East & Africa Pharmacovigilance Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pharmacovigilance Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Details
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Pharmacovigilance Introduction
11.1.4 Eli Lilly and Company Revenue in Pharmacovigilance Business (2016-2021)
11.1.5 Eli Lilly and Company Recent Development
11.2 ICON plc
11.2.1 ICON plc Company Details
11.2.2 ICON plc Business Overview
11.2.3 ICON plc Pharmacovigilance Introduction
11.2.4 ICON plc Revenue in Pharmacovigilance Business (2016-2021)
11.2.5 ICON plc Recent Development
11.3 Elsevier
11.3.1 Elsevier Company Details
11.3.2 Elsevier Business Overview
11.3.3 Elsevier Pharmacovigilance Introduction
11.3.4 Elsevier Revenue in Pharmacovigilance Business (2016-2021)
11.3.5 Elsevier Recent Development
11.4 Chiltern
11.4.1 Chiltern Company Details
11.4.2 Chiltern Business Overview
11.4.3 Chiltern Pharmacovigilance Introduction
11.4.4 Chiltern Revenue in Pharmacovigilance Business (2016-2021)
11.4.5 Chiltern Recent Development
11.5 Atlantic Research Group
11.5.1 Atlantic Research Group Company Details
11.5.2 Atlantic Research Group Business Overview
11.5.3 Atlantic Research Group Pharmacovigilance Introduction
11.5.4 Atlantic Research Group Revenue in Pharmacovigilance Business (2016-2021)
11.5.5 Atlantic Research Group Recent Development
11.6 Mapi Group
11.6.1 Mapi Group Company Details
11.6.2 Mapi Group Business Overview
11.6.3 Mapi Group Pharmacovigilance Introduction
11.6.4 Mapi Group Revenue in Pharmacovigilance Business (2016-2021)
11.6.5 Mapi Group Recent Development
11.7 Accenture Plc.
11.7.1 Accenture Plc. Company Details
11.7.2 Accenture Plc. Business Overview
11.7.3 Accenture Plc. Pharmacovigilance Introduction
11.7.4 Accenture Plc. Revenue in Pharmacovigilance Business (2016-2021)
11.7.5 Accenture Plc. Recent Development
11.8 Clinquest Group B.V.
11.8.1 Clinquest Group B.V. Company Details
11.8.2 Clinquest Group B.V. Business Overview
11.8.3 Clinquest Group B.V. Pharmacovigilance Introduction
11.8.4 Clinquest Group B.V. Revenue in Pharmacovigilance Business (2016-2021)
11.8.5 Clinquest Group B.V. Recent Development
11.9 GSK
11.9.1 GSK Company Details
11.9.2 GSK Business Overview
11.9.3 GSK Pharmacovigilance Introduction
11.9.4 GSK Revenue in Pharmacovigilance Business (2016-2021)
11.9.5 GSK Recent Development
11.10 PRA Health Sciences, Inc.
11.10.1 PRA Health Sciences, Inc. Company Details
11.10.2 PRA Health Sciences, Inc. Business Overview
11.10.3 PRA Health Sciences, Inc. Pharmacovigilance Introduction
11.10.4 PRA Health Sciences, Inc. Revenue in Pharmacovigilance Business (2016-2021)
11.10.5 PRA Health Sciences, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Pharmacovigilance Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Contract Outsourcing
Table 4. Global Pharmacovigilance Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Pharmacovigilance Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pharmacovigilance Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Pharmacovigilance Market Share by Regions (2016-2021)
Table 8. Global Pharmacovigilance Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Pharmacovigilance Market Share by Regions (2022-2027)
Table 10. Pharmacovigilance Market Trends
Table 11. Pharmacovigilance Market Drivers
Table 12. Pharmacovigilance Market Challenges
Table 13. Pharmacovigilance Market Restraints
Table 14. Global Pharmacovigilance Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Pharmacovigilance Market Share by Players (2016-2021)
Table 16. Global Top Pharmacovigilance Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacovigilance as of 2020)
Table 17. Ranking of Global Top Pharmacovigilance Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Pharmacovigilance Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Pharmacovigilance Product Solution and Service
Table 21. Date of Enter into Pharmacovigilance Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pharmacovigilance Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Pharmacovigilance Revenue Market Share by Type (2016-2021)
Table 25. Global Pharmacovigilance Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Pharmacovigilance Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Pharmacovigilance Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Pharmacovigilance Revenue Market Share by Application (2016-2021)
Table 29. Global Pharmacovigilance Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Pharmacovigilance Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Pharmacovigilance Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Pharmacovigilance Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Pharmacovigilance Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Pharmacovigilance Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Pharmacovigilance Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Pharmacovigilance Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Pharmacovigilance Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Pharmacovigilance Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Pharmacovigilance Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Pharmacovigilance Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Pharmacovigilance Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Pharmacovigilance Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Pharmacovigilance Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Pharmacovigilance Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Pharmacovigilance Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Pharmacovigilance Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pharmacovigilance Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Pharmacovigilance Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Pharmacovigilance Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Pharmacovigilance Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Pharmacovigilance Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Pharmacovigilance Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Pharmacovigilance Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Pharmacovigilance Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Pharmacovigilance Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Pharmacovigilance Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Pharmacovigilance Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Pharmacovigilance Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pharmacovigilance Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Pharmacovigilance Market Size by Country (2022-2027) & (US$ Million)
Table 61. Eli Lilly and Company Company Details
Table 62. Eli Lilly and Company Business Overview
Table 63. Eli Lilly and Company Pharmacovigilance Product
Table 64. Eli Lilly and Company Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million)
Table 65. Eli Lilly and Company Recent Development
Table 66. ICON plc Company Details
Table 67. ICON plc Business Overview
Table 68. ICON plc Pharmacovigilance Product
Table 69. ICON plc Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million)
Table 70. ICON plc Recent Development
Table 71. Elsevier Company Details
Table 72. Elsevier Business Overview
Table 73. Elsevier Pharmacovigilance Product
Table 74. Elsevier Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million)
Table 75. Elsevier Recent Development
Table 76. Chiltern Company Details
Table 77. Chiltern Business Overview
Table 78. Chiltern Pharmacovigilance Product
Table 79. Chiltern Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million)
Table 80. Chiltern Recent Development
Table 81. Atlantic Research Group Company Details
Table 82. Atlantic Research Group Business Overview
Table 83. Atlantic Research Group Pharmacovigilance Product
Table 84. Atlantic Research Group Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million)
Table 85. Atlantic Research Group Recent Development
Table 86. Mapi Group Company Details
Table 87. Mapi Group Business Overview
Table 88. Mapi Group Pharmacovigilance Product
Table 89. Mapi Group Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million)
Table 90. Mapi Group Recent Development
Table 91. Accenture Plc. Company Details
Table 92. Accenture Plc. Business Overview
Table 93. Accenture Plc. Pharmacovigilance Product
Table 94. Accenture Plc. Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million)
Table 95. Accenture Plc. Recent Development
Table 96. Clinquest Group B.V. Company Details
Table 97. Clinquest Group B.V. Business Overview
Table 98. Clinquest Group B.V. Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million)
Table 99. Clinquest Group B.V. Recent Development
Table 100. GSK Company Details
Table 101. GSK Business Overview
Table 102. GSK Pharmacovigilance Product
Table 103. GSK Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million)
Table 104. GSK Recent Development
Table 105. PRA Health Sciences, Inc. Company Details
Table 106. PRA Health Sciences, Inc. Business Overview
Table 107. PRA Health Sciences, Inc. Pharmacovigilance Product
Table 108. PRA Health Sciences, Inc. Revenue in Pharmacovigilance Business (2016-2021) & (US$ Million)
Table 109. PRA Health Sciences, Inc. Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmacovigilance Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Contract Outsourcing Features
Figure 4. Global Pharmacovigilance Market Share by Application: 2020 VS 2027
Figure 5. Pharma and Biotech Companies Case Studies
Figure 6. Contract Research Organizations (CROs) Case Studies
Figure 7. Business Process Outsourcing (BPO) Firms Case Studies
Figure 8. Other Pharmacovigilance Service Providers Case Studies
Figure 9. Pharmacovigilance Report Years Considered
Figure 10. Global Pharmacovigilance Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Pharmacovigilance Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Pharmacovigilance Market Share by Regions: 2020 VS 2027
Figure 13. Global Pharmacovigilance Market Share by Regions (2022-2027)
Figure 14. Global Pharmacovigilance Market Share by Players in 2020
Figure 15. Global Top Pharmacovigilance Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacovigilance as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Pharmacovigilance Revenue in 2020
Figure 17. Global Pharmacovigilance Revenue Market Share by Type (2016-2021)
Figure 18. Global Pharmacovigilance Revenue Market Share by Type (2022-2027)
Figure 19. North America Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Pharmacovigilance Market Share by Type (2016-2027)
Figure 21. North America Pharmacovigilance Market Share by Application (2016-2027)
Figure 22. North America Pharmacovigilance Market Share by Country (2016-2027)
Figure 23. United States Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Pharmacovigilance Market Share by Type (2016-2027)
Figure 27. Europe Pharmacovigilance Market Share by Application (2016-2027)
Figure 28. Europe Pharmacovigilance Market Share by Country (2016-2027)
Figure 29. Germany Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Pharmacovigilance Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Pharmacovigilance Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Pharmacovigilance Market Share by Region (2016-2027)
Figure 39. China Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Pharmacovigilance Market Share by Type (2016-2027)
Figure 47. Latin America Pharmacovigilance Market Share by Application (2016-2027)
Figure 48. Latin America Pharmacovigilance Market Share by Country (2016-2027)
Figure 49. Mexico Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Pharmacovigilance Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Pharmacovigilance Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Pharmacovigilance Market Share by Country (2016-2027)
Figure 55. Turkey Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Eli Lilly and Company Revenue Growth Rate in Pharmacovigilance Business (2016-2021)
Figure 59. ICON plc Revenue Growth Rate in Pharmacovigilance Business (2016-2021)
Figure 60. Elsevier Revenue Growth Rate in Pharmacovigilance Business (2016-2021)
Figure 61. Chiltern Revenue Growth Rate in Pharmacovigilance Business (2016-2021)
Figure 62. Atlantic Research Group Revenue Growth Rate in Pharmacovigilance Business (2016-2021)
Figure 63. Mapi Group Revenue Growth Rate in Pharmacovigilance Business (2016-2021)
Figure 64. Accenture Plc. Revenue Growth Rate in Pharmacovigilance Business (2016-2021)
Figure 65. Clinquest Group B.V. Revenue Growth Rate in Pharmacovigilance Business (2016-2021)
Figure 66. GSK Revenue Growth Rate in Pharmacovigilance Business (2016-2021)
Figure 67. PRA Health Sciences, Inc. Revenue Growth Rate in Pharmacovigilance Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---